The genetics of Parkinson's disease: unlocking personalised treatments Wednesday, May 22, 2024 9:00 AM British Summer Time 1 hour, 30 minutes

We are pleased to invite you to our Lancet Webinar on the genetics of Parkinson's disease: unlocking personalised treatments on May 22, 2024, at 09:00 BST/10:00 CEST. Attendance is free with registration and you can register for the webinar here. Wed, May 22, 2024 09:00 BST / 10:00 CEST https://event.on24.com/wcc/r/4570809/A3C55D362C7C64AB03CC706339D52C75?partnerref=hubspot_email_registration1_infocusbrainhealth_geneticsofparkinsons24&utm_campaign=infocusbrainhealth&utm_medium=email&_hsenc=p2ANqtz--hUIEnV6EVjCIg_xQKhlvXa7UCnIVIj-l_IGLJUGdf1ar89ZRT6Py-395idHRa2uE-QatLgdg6d1atoY9OJ8oDxh-_Qw&_hsmi=305204402&utm_content=305178461&utm_source=hs_email&hsCtaTracking=162f0144-4f2e-497f-9f96-8c65f7460cb7%7C7da0b395-3d2c-4860-abe6-2e5d7b9637a1 Chaired by Elena Becker-Barroso, Editor-in-Chief of The Lancet Neurology, and with a foreword from Kumsal Bayazit, CEO of Elsevier, hear from a panel of experts as they explore advances in Parkinson’s disease genetics and how these have influenced clinical practice and can contribute to new diagnostic criteria: Thomas Gasser, MD, Professor of Neurology, Hertie-Institute for Clinical Brain Research, Department for Neurodegenerative Diseases, University of Tübingen, Germany Tanya Simuni, MD, Arthur C. Nielsen Jr. Professor of Neurology, Director, Parkinson's Disease and Movement Disorders Center, Northwestern University Feinberg School of Medicine, USA Christine Klein, MD, FEAN, Professor of Neurology and Neurogenetics, University of Lübeck and University Hospital Schleswig-Holstein, Germany The prevalence of Parkinson's disease is the fastest growing among neurodegenerative disorders. Due to longer life expectancies and a higher proportion of elderly people, prevalence of the disease will continue to rise unless prevention strategies are found. The discovery of genetic variants that can lead to this movement disorder has revolutionised our understanding of the mechanisms that must be tackled to stop or delay neurodegeneration.